Financial results - GHEMIDRAG MED S.R.L.

Financial Summary - Ghemidrag Med S.r.l.
Unique identification code: 40864898
Registration number: J27/470/2019
Nace: 8622
Sales - Ron
14.470
Net Profit - Ron
2.125
Employees
Open Account
Company Ghemidrag Med S.r.l. with Fiscal Code 40864898 recorded a turnover of 2024 of 14.470, with a net profit of 2.125 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ghemidrag Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 5.213 7.859 25.120 19.855 20.639 14.470
Total Income - EUR - - - - 5.213 7.859 25.121 19.855 20.639 15.895
Total Expenses - EUR - - - - 1.914 959 6.294 9.121 11.957 13.076
Gross Profit/Loss - EUR - - - - 3.300 6.900 18.827 10.735 8.683 2.819
Net Profit/Loss - EUR - - - - 3.143 6.680 18.073 10.139 7.047 2.125
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -29.5%, from 20.639 euro in the year 2023, to 14.470 euro in 2024. The Net Profit decreased by -4.882 euro, from 7.047 euro in 2023, to 2.125 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ghemidrag Med S.r.l.

Rating financiar

Financial Rating -
GHEMIDRAG MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ghemidrag Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ghemidrag Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ghemidrag Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ghemidrag Med S.r.l. - CUI 40864898

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 33 0 16.157 12.467 10.022 6.413
Current Assets - - - - 3.252 9.931 14.095 2.626 3.714 9.678
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 0 0 442 2.501 992 287
Cash - - - - 3.252 9.931 13.653 126 2.722 9.391
Shareholders Funds - - - - 3.185 9.805 27.661 6.459 13.486 15.536
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 99 126 2.592 8.634 250 555
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 9.678 euro in 2024 which includes Inventories of 0 euro, Receivables of 287 euro and cash availability of 9.391 euro.
The company's Equity was valued at 15.536 euro, while total Liabilities amounted to 555 euro. Equity increased by 2.125 euro, from 13.486 euro in 2023, to 15.536 in 2024.

Risk Reports Prices

Reviews - Ghemidrag Med S.r.l.

Comments - Ghemidrag Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.